基于主要癌症部位的静脉血栓塞结结果的变化:RIETE注册表分析
Javier Trujillo-Santos1, Cihan Ay2, Behnood Bikdeli3
1Department of Internal Medicine, Hospital General Universitario Santa Lucía, Cartagena, Spain; UCAM - Universidad Católica San Antonio de Murcia, Guadalupe, Spain.
JACC. Advances
|August 23, 2025
概括
患有静脉血栓塞栓症 (VTE) 的癌症患者面临更高的复发和出血风险,这些风险因癌症类型而异. 根据这些特定的风险,建议采用个性化的抗凝策略.
科学领域:
- 癌症学
- 血液学
- 临床研究
背景情况:
- 患有癌症相关静脉血栓塞栓症 (VTE) 的患者患有静脉血栓塞栓复发和出血的风险较高.
- 癌症部位对这些风险的影响尚不清楚.
研究的目的:
- 在不同癌症部位进行90天的复发性VTE或与VTE相关的死亡和大出血风险比较.
- 为患有静脉血栓炎的癌症患者提供个性化抗凝策略.
主要方法:
- 来自RIETE注册表的18660名癌症和静脉瘤患者的分析.
- 使用多变量Cox模型和Fine-Gray竞争风险分析.
- 敏感性分析包括倾向性得分匹配和癌症部位分组分层.
主要成果:
- 与非癌症患者相比,与癌症相关的血栓形成患者的风险显著增加 (aHR: 2.54) 和严重出血 (aHR: 1. 40).
- 肺癌和胰腺癌的血栓发生风险最高,而胃肠癌,泌尿器癌和胰腺癌的出血风险最高.
- 在所有敏感性分析中,包括倾向性得分匹配,结果一致.
结论:
- 癌症患者的静脉血栓塞栓和出血风险因主要癌症部位而异.
- 这些发现强调了根据个体癌症类型进行量身定制的抗凝治疗的必要性.
相关概念视频
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Venous Thrombosis I: Introduction
40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
Venous Thrombosis IV: Nursing Management
23
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
23
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
34
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
34
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


